Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
Mauri, Laura MD, MSc a,b,*; Kereiakes, Dean J. MD c; Normand, Sharon-Lise T. PhD b,d; Wiviott, Stephen D. MD a,b; Cohen, David J. MD, MSc e; Holmes, David R. MD f; Bangalore, Sripal MD a,b; Cutlip, Donald E. MD b,g; Pencina, Michael PhD h; Massaro, Joseph M. PhD h
American Heart Journal.
160(6):1035-1041e1, December 2010.
(Format: HTML, PDF)